Dr. Mamatha Bhat, a hepatologist with the Ajmera Transplant Centre at UHN, and...
Dr. Mamatha Bhat, a hepatologist with the Ajmera Transplant Centre at UHN, and Dr. Bo Wang, Artificial Intelligence Lead at the Peter Munk Cardiac Centre, are co-senior authors of the study published in Lancet Digital Health

Photos: Courtesy Drs. Bhat and Wang

Outcome prediction

Deep learning to maximize lifespan after liver transplant

Researchers from the Canadian University Healh Network (UHN) have developed and validated a deep learning model to predict a patient's long-term outcome after receiving a liver transplant.

First of its kind in the field of Transplantation, this model is the result of a collaboration between the Ajmera Transplant Centre and Peter Munk Cardiac Centre (PMCC). The study, published in Lancet Digital Health, shows it can significantly improve long-term survival and quality of life for liver transplant recipients. "Historically, we have seen good advances in one-year post-transplant outcomes, but survival in the longer term hasn't significantly improved in the past decades," explains Dr. Mamatha Bhat, a hepatologist with the Ajmera Transplant Centre at UHN, and co-senior author of the study. "This model can guide physicians and help anticipate when and how complications may rise. It can really be paradigm-changing in how we support liver transplant recipients in personalizing their care and helping them live better and longer."

For liver transplant recipients, long-term survival beyond one-year is significantly compromised by an increased risk of cancer, cardiovascular mortality, infection and graft failure. Clinical tools to identify patients at risk of these complications are limited.

Deep learning enables timely processing of large-scale datasets, finding patterns and signals that can aid clinicians in better predicting the clinical outcomes and creating specific treatment recommendations

Bo Wang

This model will help clinicians enhance post-liver transplant care using machine learning, allowing them to identify potential risks when formulating patient-specific treatment plans. The study results show this model is more than 80 per cent accurate in predicting potential complications for liver transplant recipients at any point post-transplantation, based on their medical history and comparing to the millions of data points compiled using artificial intelligence (AI). "Deep learning enables timely processing of large-scale datasets, finding patterns and signals that can aid clinicians in better predicting the clinical outcomes and creating specific treatment recommendations," says Dr. Bo Wang, AI Lead at the PMCC, and co-senior author of this study.

The algorithms for this model were created based on the Scientific Registry of Transplant Recipients (SRTR) – a national medical database in the United States, with data from more than 42,000 liver transplant recipients. They were then validated using the local dataset from UHN's Ajmera Transplant Centre, which had over 3,200 cases. The research team now plans to share this model with clinicians so that it can be used across the world. Work is also in progress to evaluate what are the best formats to streamline its use, either developing a software or mobile application.


Source: University Health Network

15.04.2021

Read all latest stories

Related articles

Photo

AI-assisted analysis

Prediciting viral infections with microscopy & deep learning

When viruses infect cells, changes in the cell nucleus occur, and these can be observed through fluorescence microscopy. Using fluoresence images from live cells, researchers at the University of…

Photo

Bioengineering

Producing transplantable livers in the laboratory

Researchers at the Human Genome and Stem Cell Research Center (HUG-CELL), hosted by the University of São Paulo’s Institute of Biosciences (IB-USP) in Brazil, have developed a technique to…

Photo

At ECR 2021

AI experts tackle organ segmentation and health economics

AI is revamping workflows and experts showed how radiologists can integrate it into their department to improve daily practice and healthcare at ECR. The panel also discussed the health economics…

Related products

Canon – Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon – Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
Canon - HIT Automation Platform

Artificial Intelligence

Canon - HIT Automation Platform

Canon Medical Systems Europe B.V.
Canon - Vantage Elan NX Edition

1.5 Tesla

Canon - Vantage Elan NX Edition

Canon Medical Systems Europe B.V.
Fujifilm · REiLI

Artificial Intelligence

Fujifilm · REiLI

FUJIFILM EUROPE GmbH
Fujifilm Wako – Autokit Total Ketone Bodies Assay

Clinical Chemistry

Fujifilm Wako – Autokit Total Ketone Bodies Assay

FUJIFILM Wako Chemicals Europe GmbH
Agfa - Smart XR

Accessories/ Complementary Systems

Agfa - Smart XR

Agfa HealthCare
Subscribe to Newsletter